Impact of SNAP Benefits on Outcomes of Care and Healthcare Use for Persons with Type II Diabetes
As the nation’s single largest program to address food insecurity, more than 47 million American’s receive Supplemental Nutrition Assistance Program (SNAP) income maintenance benefits to aid themselves and families to meet basic needs for food (USDA, 2013).
However, low-income and food insecure adults with diabetes are more likely to have poor glycemic control, practice cost-related medication non-adherence, and report difficulty affording a diabetic diet.
To examine the impact of SNAP benefits on health care use and outcomes for persons with Type II Diabetes (T2D), a two-group sample of SNAP recipients and SNAP eligible persons was identified from the Medical Expenditure Panel Survey. Analyses showed that SNAP enrollment was protective for diabetic retinopathy, associated with greater use of healthcare services and a factor in managing T2D with diet modification.
This study highlights the importance of public welfare benefits to supplement the resources of health providers to achieve positive health outcomes.
Learning Areas:Administer health education strategies, interventions and programs
Chronic disease management and prevention
Planning of health education strategies, interventions, and programs
Public health administration or related administration
Public health or related public policy
Public health or related research
Demonstrate the importance of SNAP benefits in managing care for Type II Diabetes. Describe use of the MEPS public use files for health outcomes research.
Keyword(s): Health Care Delivery, Diabetes
Qualified on the content I am responsible for because: I am a health services researcher with expertise in analyses of large administrative data files for treatment assessment and healthcare management. I conducted the research for this study which is an example of research I have conducted in health outcomes for teaching and scholarly activities
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.